XKR9

Chr 8

XK related 9

Also known as: XRG9, hXKR9

XKR9 encodes a phospholipid scramblase that promotes phosphatidylserine exposure on apoptotic cell surfaces, serving as a signal for cellular engulfment during programmed cell death. Mutations in XKR9 cause Birk-Barel syndrome, characterized by intellectual disability, congenital microcephaly, and dysmorphic features, with autosomal recessive inheritance. The gene shows very high constraint against loss-of-function variants (pLI ~0), indicating that complete loss of function is likely not tolerated.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
2
Pubs (1 yr)
34
P/LP submissions
0%
P/LP missense
1.56
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryXKR9
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
34 unique Pathogenic / Likely Pathogenic· 58 VUS of 108 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.56LOEUF
pLI 0.000
Z-score 0.04
OE 0.99 (0.641.56)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-1.71Z-score
OE missense 1.35 (1.221.50)
252 obs / 186.2 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.99 (0.641.56)
00.351.4
Missense OE1.35 (1.221.50)
00.61.4
Synonymous OE1.12
01.21.6
LoF obs/exp: 13 / 13.2Missense obs/exp: 252 / 186.2Syn Z: -0.78
DN
0.6357th %ile
GOF
0.76top 25%
LOF
0.2580th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

108 submitted variants in ClinVar

Classification Summary

Pathogenic33
Likely Pathogenic1
VUS58
Likely Benign6
Benign1
33
Pathogenic
1
Likely Pathogenic
58
VUS
6
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
33
0
33
Likely Pathogenic
0
0
1
0
1
VUS
0
51
7
0
58
Likely Benign
0
4
2
0
6
Benign
0
0
1
0
1
Total05544099

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

XKR9 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC